Prosecution Insights
Last updated: July 17, 2026
Application No. 17/783,669

NOVEL BINDER COMPOSITION

Non-Final OA §102
Filed
Jun 09, 2022
Priority
Dec 16, 2019 — EU 19216428.3 +1 more
Examiner
EGWIM, KELECHI CHIDI
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BASF SE
OA Round
3 (Non-Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
557 granted / 797 resolved
+4.9% vs TC avg
Moderate +14% lift
Without
With
+13.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
39 currently pending
Career history
845
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
42.6%
+2.6% vs TC avg
§102
49.5%
+9.5% vs TC avg
§112
2.9%
-37.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 797 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In view of the appeal brief filed on 1/30/2026, PROSECUTION IS HEREBY REOPENED. New grounds of rejection are set forth below. To avoid abandonment of the application, appellant must exercise one of the following two options: (1) file a reply under 37 CFR 1.111 (if this Office action is non-final) or a reply under 37 CFR 1.113 (if this Office action is final); or, (2) initiate a new appeal by filing a notice of appeal under 37 CFR 41.31 followed by an appeal brief under 37 CFR 41.37. The previously paid notice of appeal fee and appeal brief fee can be applied to the new appeal. If, however, the appeal fees set forth in 37 CFR 41.20 have been increased since they were previously paid, then appellant must pay the difference between the increased fees and the amount previously paid. A Supervisory Patent Examiner (SPE) has approved of reopening prosecution by signing below: /ROBERT S JONES JR/ Supervisory Patent Examiner, Art Unit 1762 Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 18-23 and 25-34 are rejected under 35 U.S.C. 102(a)(1)/(a)(2) as being anticipated by Cosysns et al. (US 20120121921). In ¶ 10, and claims 1 and 10-14, Cosysns et al. teach an aqueous (waterborne) coating composition comprising pigments, preferably titanium dioxide (See ¶ 113), and an aqueous polymer dispersion (latex) comprising a polymer prepared from polymerizing by free radical emulsion polymerization of: from 20 to 75% by weight of tert-butyl (meth)acrylate; from 25 to 80% by weight of monomer (M1) comprising: c) at least 50% by weight of main monomer (HM) preferably comprising n-butyl acrylate (See ¶’s 18 and 36 and 38), and d) at least 0.1 % of secondary monomers (NM) which are particularly preferably (meth)acrylic acid, (meth) acrylamide, itaconic acid, and mixtures of them thereof. (See ¶’s 40 and 41). It is noted that the Examiner understands the term “the total amount of the monomer composition M” in claims 18, 26 and 27 to mean the total amount of a), b), c) and d) according to the independent claims. In Example N, Cosysns et al. teaches a polymer comprising: 54.69 wt. % [(210/384)x100] of tert-butyl acrylate, 40.93 wt. % [(157.2/384)x100] of n-butyl acrylate, 2 wt. % [(7.8/384)x100] of acrylic acid, and 2.3 wt. % [(9/384)X100] of acrylamide. wherein the combined weight of tert-butyl acrylate and n-butyl acrylate are above 90% of the total amount of a), b), c) and d). In Example S, Cosysns et al. teaches a polymer comprising: 49.78 wt. % [(210/421.8)x100] of tert-butyl acrylate, 46.23 wt. % [(195/421.8)x100] of n-butyl acrylate, 1.85 wt. % [(7.8/421.8)x100] of acrylic acid, and 2.13 wt. % [(9/421.8)X100] of acrylamide. wherein the combined weight of tert-butyl acrylate and n-butyl acrylate are above 90% of the total amount of a), b), c) and d). Thus, the requirements for rejection under 35 U.S.C. 102(a)(1)/(a)(2) are met. Response to Arguments Applicant's arguments filed 1/30/2026 have been fully considered but they are not persuasive. Applicant argues that (a) t-butyl acrylate and (b) n-butyl acrylate together in the range of 90.0 to 99.8 wt% based on the total weight of the monomers is not disclosed by Cosyns et al. However, Cosyns et al. teach from 20 to 75% by weight of tert-butyl acrylate and from 25 to 80% by weight of the monomer (M1) comprising n-butyl acrylate, based on the total amount of a), b), c) and d). Thus, the 90.0 to 99.8 wt% falls within the upper limits for (a) t-butyl acrylate and (b) n-butyl acrylate taught by Cosyns et al. Further, in each of the Examples N and S, above, monomer a) and b) together are 95.62% and 96.01%, respectively, based on the total weight of the monomers a), b), c) and d) together, which fall within the range of 90.0 to 99.8 wt%. Contrary to applicant’s arguments, as seen in the teachings of Cosyns et al. cited above, the composition which meets all of the requirements of the claims are taught. Regarding the lack of listing of the acrylic acid in Table 1, please see the actual text of the examples (N and S) for the amounts of acrylic acid cited above in Cosyns et al. Regarding the argument that n-butyl acrylate is taught within a group of numerous potential monomers and multiple efforts of picking and choosing would be required to anticipate the claims, it is noted that in ¶ 38, n-butyl acrylate is taught within a small group, which is sufficient to anticipate the use of n-butyl acrylate in the present invention. Further, the examples cited above explicitly require n-butyl acrylate in the claimed range, along with t-butyl acrylate. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KELECHI CHIDI EGWIM whose telephone number is (571)272-1099. The examiner can normally be reached M-Th 9-7. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KELECHI C EGWIM/Primary Examiner, Art Unit 1762 KCE
Read full office action

Prosecution Timeline

Show 2 earlier events
Jul 08, 2025
Response Filed
Sep 30, 2025
Final Rejection mailed — §102
Dec 01, 2025
Notice of Allowance
Dec 01, 2025
Response after Non-Final Action
Dec 17, 2025
Response after Non-Final Action
Jan 30, 2026
Response after Non-Final Action
Feb 16, 2026
Response after Non-Final Action
May 12, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679964
TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID, PRODUCTION THEREOF AND USE THEREOF AS PLASTICIZERS
2y 9m to grant Granted Jul 14, 2026
Patent 12649869
METHOD FOR PRODUCING A PRESSURE-SENSITIVE ADHESIVE BASED ON AN ALKOXYLATED, IN PARTICULAR ETHOXYLATED, SILANE-CONTAINING POLYMER, PRESSURE-SENSITIVE ADHESIVE PRODUCED ACCORDING TO THIS METHOD, AND USE THEREOF
4y 6m to grant Granted Jun 09, 2026
Patent 12643989
ANTIMICROBIAL MEDICAL GLOVE
4y 5m to grant Granted Jun 02, 2026
Patent 12630660
AQUEOUS DISPERSION OF POLYMER PARTICLES AND USES THEREOF AS AN ADHESIVE COMPOSITION
4y 2m to grant Granted May 19, 2026
Patent 12617884
ORGANIC FINE PARTICLE
4y 1m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
84%
With Interview (+13.9%)
3y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 797 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month